Scarica l'app Stockscreener
6.82
11.26%
0.69
Dopo l'orario di chiusura:
6.82
Nuvectis Pharma Inc Borsa (NVCT) Ultime notizie
Is Nuvectis Pharma Inc. trending in predictive chart modelsAI Entry Timing Prediction for Swing Traders - Newser
Developing predictive dashboards with Nuvectis Pharma Inc. dataFree Price Action Based Buy Opportunity List - Newser
What makes Nuvectis Pharma Inc. stock price move sharplyWeekly Breakout Forecast with Entry Zones - Newser
Nuvectis initiates phase 1b program for cancer drug NXP900 - Investing.com
Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900 - GlobeNewswire
Nuvectis Expands Cancer Drug Trial to Target Multiple Resistant Tumors with Precision Medicine - Stock Titan
Key resistance and support levels for Nuvectis Pharma Inc.Volume Spike Detection for Early Breakouts - Newser
Is it time to cut losses on Nuvectis Pharma Inc.Breakout Monitoring with Momentum Analysis - Newser
How to track smart money flows in Nuvectis Pharma Inc.Strategy Builder for Growth Focused Traders - Newser
Volume spikes in Nuvectis Pharma Inc. stock – what they meanFree Pattern Detection for Entry Confirmation - Newser
Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) stock price dropped 12% last week; retail investors would not be happy - simplywall.st
Does Nuvectis Pharma Inc. fit your quant trading modelFree Exit Ready Momentum Stock Watchlist - Newser
Will Nuvectis Pharma Inc. stock recover after recent dropReal Time Trade Execution Alert Plan - Newser
How to forecast Nuvectis Pharma Inc. trends using time seriesWatchlist Generator for Smart Money Signals - Newser
Why Nuvectis Pharma Inc. stock attracts strong analyst attentionFree Expert Verified Stock Trade Ideas - Newser
Nuvectis Pharma cuts NXP800 in ovarian cancer after early failure - MSN
Nuvectis Pharma Inc. stock daily chart insightsSwing Watchlist With Tight Stop Placement - Newser
Nuvectis Pharma Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingTrend Reversal Watch with Entry Signals - Newser
Using R and stats models for Nuvectis Pharma Inc. forecastingFree Trade Ready Stock Watch for Short Term - Newser
Q3 EPS Estimates for Nuvectis Pharma Reduced by Roth Capital - Defense World
Will a bounce in Nuvectis Pharma Inc. offer an exitFree Consistent Profit Pattern Recognition Tools - Newser
What indicators show strength in Nuvectis Pharma Inc.Free Real Time Alerts Based on AI Prediction - Newser
what makes nuvectis pharma inc. stock price move sharplyHigh Probability Trade Outcome Prediction - Newser
Nuvectis Pharma’s Strategic Focus on NXP900 and Positive Outlook Amidst Promising Developments - TipRanks
Nuvectis Pharma Reports Q2 2025 Financial Results and Progress - TipRanks
Exit strategy if you’re trapped in Nuvectis Pharma Inc.Stable Profit Zone and Loss Control Analysis - Newser
Nuvectis Pharma reports Q2 EPS (30c) vs. (26c) last year - TipRanks
Nuvectis Pharma: A Biotech Gem in the Shadows of GAAP Losses - AInvest
Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Nuvectis Reports Clinical Trial Success: NXP900 Cancer Drug Advances as Cash Position Strengthens to $39M - Stock Titan
Nuvectis Pharma (NASDAQ:NVCT) Given New $10.00 Price Target at HC Wainwright - Defense World
HC Wainwright Lowers Nuvectis Pharma (NASDAQ:NVCT) Price Target to $10.00 - Defense World
Nuvectis Pharma: Reprioritized Pipeline and Promising Clinical Progress Supports Buy Rating - AInvest
Nuvectis Pharma stock price target lowered to $10 at H.C. Wainwright - Investing.com Nigeria
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):